|
|
|
|
| LEADER |
01005cas a2200289 a 4500 |
| 001 |
9416272 |
| 003 |
DNLM |
| 005 |
20130509062054.0 |
| 008 |
950914d19721997nyumr p 0 0eng |
| 022 |
|
|
|a 0734-1989
|l 0734-1989
|
| 035 |
|
|
|a (DNLM)N14495000(s)
|
| 035 |
|
|
|a (OCoLC)08702334
|
| 040 |
|
|
|a DNLM
|c DNLM
|
| 060 |
0 |
0 |
|a QV 772
|b N5286
|
| 222 |
|
0 |
|a New drug commentary
|
| 245 |
0 |
0 |
|a New drug commentary.
|
| 260 |
|
|
|a New Rochelle, N.Y. :
|b Paregian Associates,
|
| 300 |
|
|
|a v.
|
| 310 |
|
|
|a Monthly
|
| 362 |
1 |
|
|a Ceased with: Vol. 24, no. 10 (1997).
|
| 500 |
|
|
|a Description based on: Vol. 19, no. 11-12 (Aug. 1993) = Issue 210; title from caption.
|
| 515 |
|
|
|a Some no. combined.
|
| 650 |
1 |
2 |
|a Drugs, Investigational
|v Catalogs.
|
| 650 |
1 |
2 |
|a Pharmaceutical Preparations
|v Catalogs.
|
| 780 |
0 |
5 |
|t International drug review
|g 1993
|
| 999 |
|
|
|c 77932
|d 77932
|
| 952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 812792
|a M-BNCS
|b M-BNCS
|h (1977)1978-83(1984)1985-88(1989).
|o M-BNCS-812792JNL-0734-1989
|p M-BNCS-812792JNL-77932
|t 1115511
|y JNL
|
